The evidence for the efficacy of cholinesterase inhibitors in the treatment of Alzheimer's disease is convincing

被引:0
|
作者
Birks, Jacqueline [1 ]
机构
[1] Univ Oxford, Ctr Stat Med, Oxford OX1 2JD, England
关键词
D O I
暂无
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
引用
收藏
页码:279 / 286
页数:8
相关论文
共 50 条
  • [41] A review on cholinesterase inhibitors for Alzheimer's disease
    Anand, Preet
    Singh, Baldev
    ARCHIVES OF PHARMACAL RESEARCH, 2013, 36 (04) : 375 - 399
  • [42] Cholinesterase inhibitors stabilize Alzheimer's disease
    Giacobini, E
    MOLECULAR BASIS OF DEMENTIA, 2000, 920 : 321 - 327
  • [43] A review on cholinesterase inhibitors for Alzheimer’s disease
    Preet Anand
    Baldev Singh
    Archives of Pharmacal Research, 2013, 36 : 375 - 399
  • [44] Cholinesterase inhibitors and Alzheimer's disease outcomes
    Garcia, Angeles
    Thompson, Kelli
    Zanibbi, Katherine
    Geick, Shannon
    Adams, Rachel
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2007, 62 (05): : 570 - 570
  • [45] Cholinesterases and cholinesterase inhibitors in Alzheimer's disease
    Rakonczay, Z.
    Nagy, K.
    ACTA PHYSIOLOGICA HUNGARICA, 2009, 96 (01) : 116 - 117
  • [46] Cholinesterase inhibitors: beyond Alzheimer's disease
    Larner, A. J.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2010, 10 (11) : 1699 - 1705
  • [47] Limited efficacy of cholinesterase inhibitors in Alzheimer's dementia
    Kornhuber, J
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2004, 72 (10) : 553 - 554
  • [48] Cholinesterases in Alzheimer’s disease and Cholinesterase inhibitors in Alzheimer therapy
    Z. Rakonczay
    I. Kovács
    Acta Biologica Hungarica, 1998, 49 (1): : 55 - 70
  • [49] Cholinesterases in Alzheimer's disease and cholinesterase inhibitors in Alzheimer therapy
    Rakonczay, Z
    Kovács, I
    ACTA BIOLOGICA HUNGARICA, 1998, 49 (01): : 55 - 70
  • [50] Re: Long-Term Efficacy and Toxicity of Cholinesterase Inhibitors in the Treatment of Alzheimer Disease
    Thorpe, Lilian
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2015, 60 (07): : 338 - 338